A Photothermal Agent with Multiple Hot Shock Proteins Inhibition for Enhanced Tumor Photothermal Therapy and Intrinsic Apoptosis
Small · 2025-08 · 21 (33)
DOI: 10.1002/smll.202504769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 20.06.2025. Verfasst von Jiexuan Zuo und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Dalian University of Technology, …. Hauptthemen laut MEDLINE: Apoptosis, Photothermal Therapy, Heat-Shock Proteins, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Science Foundation of China, Postdoctoral Fellowship Program of CPSF, "Oncology+" Open project of Liaoning Cancer Hospital.
Abstract (Originalsprache)
Photothermal therapy (PTT) represents a conventional phototherapeutic strategy for tumors; however, the high‐temperature ablation of tumors by photothermal agents inevitably induces a cascade of heat shock responses (HSRs) in tumor cells. HSRs increase tumor thermal resistance by upregulating the expression of heat shock proteins (HSPs), thereby diminishing the efficacy of PTT. In this work, a BODIPY‐based photothermal agent (PTA) with extracellular signal‐regulated kinase (ERK) pathway inhibitory effects is developed (IMH‐BDP). IMH BDP can inhibit the expression of multiple HSPs by suppressing the ERK pathway, thus enhancing the efficacy of PTT. Concurrently, ERK pathway suppression coupled with thermal stimulation during PTT can effectively induce intrinsic apoptosis in tumor cells, further improving tumor treatment efficiency. After IMH‐BDP is encapsulated into polymer nanoparticles (NPs), the formed IMH‐BDP NPs demonstrated enhanced photothermal conversion efficiency (PCE) through aggregation. The inhibition of multiple HSPs, such as HSP60 and HSP70, by IMH‐BDP NPs greatly reduced tumor thermal resistance, which, in conjunction with apoptosis, achieved nearly complete tumor ablation in tumor‐bearing mice after laser irradiation at a safe power density (0.3 W cm⁻ 2 , 808 nm). This design strategy for a photothermal agent that inhibits multiple heat shock proteins offers broader prospects for future research of PTT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials Oriented Chemical Engineering, Dalian University of Technology, Dalian, 116024, China.
- Cancer Hospital of Dalian University of Technology, Shenyang, 116000, China.
- Ningbo Institute of Dalian University of Technology, Ningbo, 315016, China.
ORCID-Profile: Wen Sun
Förderung
- National Science Foundation of China
- Postdoctoral Fellowship Program of CPSF
- "Oncology+" Open project of Liaoning Cancer Hospital
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Zuo, J., Ma, Z., Su, Z., Hu, Y., Qiu, T., Li, Y., Zeng, X., He, M., Peng, C., Fan, J., Peng, X., & Sun, W. (2025). A Photothermal Agent with Multiple Hot Shock Proteins Inhibition for Enhanced Tumor Photothermal Therapy and Intrinsic Apoptosis. Small, 21(33). https://doi.org/10.1002/smll.202504769
Vancouver
Zuo J, Ma Z, Su Z, Hu Y, Qiu T, Li Y, et al. A Photothermal Agent with Multiple Hot Shock Proteins Inhibition for Enhanced Tumor Photothermal Therapy and Intrinsic Apoptosis. Small. 2025;21(33). doi:10.1002/smll.202504769
BibTeX
@article{Zuo2025,
author = {Zuo, Jiexuan and Ma, Zhiyuan and Su, Zehou and Hu, Yifan and Qiu, Tian and Li, Yinghua and Zeng, Xiaolong and He, Maomao and Peng, Chong and Fan, Jiangli and Peng, Xiaojun and Sun, Wen},
title = {A Photothermal Agent with Multiple Hot Shock Proteins Inhibition for Enhanced Tumor Photothermal Therapy and Intrinsic Apoptosis},
journal = {Small},
year = {2025},
volume = {21},
number = {33},
doi = {10.1002/smll.202504769}
}
EUVIMED